Taking the temperature of the Association — Charlie Tredway
NAPWHA Project Officer and community advocate, Charlie Tredway, speaks to Dr John Rule (NAPWHA Senior Research Manager) about life and times during COVID-19, and ‘Chinwag: Positive Connection’, a 10-week peer-led online initiative for PLHIV.
Taking the temperature of the Association — Hayden Patterson
Hayden Patterson, Adelaide-based community activist, share stories about life and times, resilience and community during COVID-19 with Dr John Rule (NAPWHA Senior Research Manager).
Seeking expressions of interest for Body Positive Congress 2021 Advisory Group
ViiV Healthcare and NAPWHA are seeking expressions of interest from people living with HIV in Australia to contribute their lived experience and skills to the Advisory Group for the 2021 National Congress of people with HIV.
NAPWHA Annual General Meeting and Members Forum 2020
This general announcement is your invitation to our NAPWHA AGM and Members’ Forum 2020, which will be held online on Friday 27 November 2020.
Information of Prezista® (darunavir) 150 mg delisting
From 1 November 2020 Prezista® (darunavir) 150 mg tablets, used in combination with other antiretroviral agents for HIV treatment, will be discontinued for supply in Australia and removed from the Pharmaceutical Benefits Scheme.
Nominations for the Board of Directors now open
Nominations for the NAPWHA Board of Directors is now open until Friday 30 October 2020. This is a fantastic opportunity for inspirational leaders who have a genuine passion for advancing the rights of people living with HIV.